Tradestie Institutional Equity Comparison Engine

XCH vs BGM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BGM Overall Edge

BGM Captures Institutional Edge (2โ€“0 Pillars ยท 8โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BGM Group Ltd. Class A Ordinary Shares (BGM) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, XCH trades at N/M Forward P/E with -158.7% operating margin (-17.5% YoY revenue) versus BGM at N/M Forward P/E and -23.4% operating margin (+69.8% YoY). In options structure, XCH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BGM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
XCH N/M vs BGM N/M Fwd P/E
Growth & Margin Winner BGM
Op Margin -158.7% vs -23.4% ยท YoY -17.5% vs +69.8%
Momentum & Technical Winner BGM
1Y +131.2% vs -17.5% ยท 52W Pos 44% vs 74%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
XCH NASDAQ
XCHG Limited American Depositary Share
Power, Distribution & Specialty Transformers
$2.77
-9.9% 1D
Market Cap $12.3M
1M Return +33.41%
1Y Return +131.25%
Forward P/E N/M
Unified AI Score
41.1 / 100 SELL
Tech 15.0 Fund 33.0 Flow 50.0 Mom 40.0
BGM NASDAQ
BGM Group Ltd. Class A Ordinary Shares
Pharmaceutical Preparations
$8.00
-1.6% 1D
Market Cap $108.6M
1M Return -21.57%
1Y Return -17.53%
Forward P/E N/M
Unified AI Score
59.6 / 100 HOLD
Tech 65.0 Fund 55.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: XCH +131.25% BGM -17.53% Spread: +166.78 pp (XCH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
XCH TTM Op. Margin: -158.7% BGM TTM Op. Margin: -23.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XCH vs BGM. Trailing 12-month operating profitability (XCH -158.7% vs BGM -23.4%) and valuation multiples (XCH N/M vs BGM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: XCH (0) vs BGM (8)
Institutional Metric XCH BGM Criterion Row Winner
Market Capitalization Scale $12.3M $108.6M Larger Scale BGM
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -17.5% +69.8% Higher Growth BGM
Operating Margin (TTM) Profitability -158.7% -23.4% Higher Margin BGM
Net Profit Margin Profitability -158.3% -44.2% Higher Margin BGM
Return on Equity (ROE) Capital Efficiency -204.7% -7.4% Higher ROE BGM
52-Week Range Position Momentum 44% ($0โ€“$6) 74% ($0โ€“$11) Stronger Trend BGM
Beta / 30D Volatility Risk Regime 4.60ฮฒ ยท 254% Vol 3.69ฮฒ ยท 80% Vol Lower Realized Risk BGM
Unified Institutional Score Composite Signal 41.1 / 100 (SELL) 59.6 / 100 (HOLD) Higher Composite BGM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full XCH vs BGM Buy Guide
XCH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live XCH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BGM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BGM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither XCH nor BGM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.